MedTrace Logo

Aspirin and Antiretroviral Therapy in HIV Infected Patients

NCT00783614 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2017-11-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the effects of HIV treatment (antiretroviral therapy) and aspirin use on risk for cardiovascular disease among HIV infected persons.

Conditions

  • HIV Infection

Interventions

DRUG

Aspirin 325mg

Patients randomized to Aspirin 325mg po daily versus placebo pill daily

DRUG

Antiretroviral therapy (ART)

Patients randomized to start ART immediately or defer use for 1 month

Sponsors & Collaborators

  • Hennepin Healthcare Research Institute

    lead OTHER

Principal Investigators

  • Jason V Baker, MD, MS · University of Minnesota; HCMC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-01-31
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00783614 on ClinicalTrials.gov